1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Insulin Pill Market
4.
Voice of Customer
4.1.
Diabetes Prevalence, By Type
4.2.
Diabetes Prevalence, By Age
4.3.
Diabetes Prevalence, By Geography
4.4.
Commonly Used Diabetes Management Solutions
4.5.
Product Awareness
4.6.
Source of Information
4.7.
Brand Awareness
5.
Executive Summary
6. Global Insulin Pill
Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Form (Tablet v/s Capsule)
6.2.2.
By Type of Insulin (Long-Acting Insulin, Short-Acting
Insulin, Rapid-Acting Insulin)
6.2.3.
By Company
6.2.4. By
Region
6.3.
Product Market Map
7. North America Insulin
Pill Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Form
7.2.2.
By Type of Insulin
7.2.3.
By Country
7.3.
North America: Country Analysis
7.3.1.
United States Insulin Pill Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Form
7.3.1.2.2.
By Type of Insulin
7.3.2.
Mexico Insulin Pill Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Form
7.3.2.2.2.
By Type of Insulin
7.3.3.
Canada Insulin Pill Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Form
7.3.3.2.2.
By Type of Insulin
8. Europe Insulin Pill
Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Form
8.2.2. By Type of Insulin
8.2.3. By Country
8.3.
Europe: Country Analysis
8.3.1.
France Insulin Pill Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Form
8.3.1.2.2.
By Type of Insulin
8.3.2.
Germany Insulin Pill Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Form
8.3.2.2.2.
By Type of Insulin
8.3.3.
United Kingdom Insulin Pill Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Form
8.3.3.2.2.
By Type of Insulin
8.3.4.
Italy Insulin Pill Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Form
8.3.4.2.2.
By Type of Insulin
8.3.5.
Spain Insulin Pill Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Form
8.3.5.2.2.
By Type of Insulin
9. Asia-Pacific Insulin
Pill Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Form
9.2.2.
By Type of Insulin
9.2.3.
By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1.
China Insulin Pill Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Form
9.3.1.2.2.
By Type of Insulin
9.3.2.
India Insulin Pill Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Form
9.3.2.2.2.
By Type of Insulin
9.3.3.
South Korea Insulin Pill Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Form
9.3.3.2.2.
By Type of Insulin
9.3.4.
Japan Insulin Pill Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Form
9.3.4.2.2.
By Type of Insulin
9.3.5.
Australia Insulin Pill Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Form
9.3.5.2.2.
By Type of Insulin
10. South America Insulin
Pill Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Form
10.2.2.
By Type of Insulin
10.2.3.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Insulin Pill Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Form
10.3.1.2.2.
By Type of Insulin
10.3.2.
Argentina Insulin Pill Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Form
10.3.2.2.2.
By Type of Insulin
10.3.3.
Colombia Insulin Pill Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Form
10.3.3.2.2.
By Type of Insulin
11. Middle East and
Africa Insulin Pill Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Form
11.2.2.
By Type of Insulin
11.2.3.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Insulin Pill Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Form
11.3.1.2.2.
By Type of Insulin
11.3.2.
Saudi Arabia Insulin Pill Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Form
11.3.2.2.2.
By Type of Insulin
11.3.3.
UAE Insulin Pill Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Form
11.3.3.2.2.
By Type of Insulin
11.3.4.
Kuwait Insulin Pill Market Outlook
11.3.4.1.
Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2.
Market Share & Forecast
11.3.4.2.1.
By Form
11.3.4.2.2.
By Type of Insulin
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends and Developments
14.
Competitive Landscape
14.1.
Oramed
Pharmaceuticals Inc.
14.2.
Novo Nordisk A/S
14.3.
vTv Therapeutics
Inc.
14.4.
Biocon Limited
14.5.
Diabetology Ltd.
14.6.
NOD Pharmaceuticals,
Inc
15.
Strategic
Recommendations
16. About Us &
Disclaimer